Literature DB >> 12051776

A role of EphB4 receptor and its ligand, ephrin-B2, in erythropoiesis.

Souichi Suenobu1, Nobuyuki Takakura, Tomohisa Inada, Yoshihiro Yamada, Hiromi Yuasa, Xiu-Qin Zhang, Seiji Sakano, Yuichi Oike, Toshio Suda.   

Abstract

Erythropoiesis is regulated not only by erythropoietin but also by microenvironments which are composed of transmembrane molecules. We have previously shown that a receptor tyrosine kinase EphB4 is predominantly expressed on human erythroid progenitors in bone marrow. EphB4 is expressed in approximately 45% of hematopoietic progenitor cells, which are CD34-positive and c-Kit-positive in human umbilical cord blood (hUCB). The transmembrane ligand for EphB4 or ephrin-B2 is expressed on bone marrow stromal cells and arterial endothelial cells. When such EphB4-positive hematopoietic progenitor cells were co-cultured with stromal cells which express ephrin-B2, they were immediately detached from stromal cells and differentiated to mature erythroid cells. At that time, expression of EphB4 immediately down-regulated. In contrast, on ephrin-B2 non-expressing stromal cells, they remained EphB4-positive cells and the generated number of mature erythroid cells was less than that on ephrin-B2 expressing stromal cells. Additionally, ephrin-B2 expression on endothelial cells up-regulated under hypoxic condition. Taken together, we propose that one of the molecular cues that regulate erythropoiesis is ephrin-B2 on stromal cells. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12051776     DOI: 10.1016/S0006-291X(02)00330-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Molecular characterization of mouse gastric epithelial progenitor cells.

Authors:  Jason C Mills; Niklas Andersson; Chieu V Hong; Thaddeus S Stappenbeck; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

Review 2.  The role of Eph/ephrin molecules in stromal–hematopoietic interactions.

Authors:  Thao M Nguyen; Agnieszka Arthur; Stan Gronthos
Journal:  Int J Hematol       Date:  2016-02       Impact factor: 2.490

3.  Expansion of CD34+ cells on telomerized human stromal cells without losing erythroid-differentiation potential in a serum-free condition.

Authors:  Masayoshi Kobune; Yutaka Kawano; Junji Kato; Yoshinori Ito; Hiroki Chiba; Kiminori Nakamura; Akihito Fujimi; Takuya Matsunaga; Hirofumi Hamada; Yoshiro Niitsu
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

4.  Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin.

Authors:  Melissa M Rhodes; Prapaporn Kopsombut; Maurice C Bondurant; James O Price; Mark J Koury
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

Review 5.  Erythroblastic islands: niches for erythropoiesis.

Authors:  Joel Anne Chasis; Narla Mohandas
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

Review 6.  Ephrin ligands and Eph receptors contribution to hematopoiesis.

Authors:  Giovanna Tosato
Journal:  Cell Mol Life Sci       Date:  2017-06-06       Impact factor: 9.261

7.  Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.

Authors:  Seema Singh; Arvind Dev; Rakesh Verma; Anamika Pradeep; Pradeep Sathyanarayana; Jennifer M Green; Aishwarya Narayanan; Don M Wojchowski
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

Review 8.  Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics.

Authors:  Erika Gucciardo; Nami Sugiyama; Kaisa Lehti
Journal:  Cell Mol Life Sci       Date:  2014-05-04       Impact factor: 9.261

9.  Roundabout 4 is expressed on hematopoietic stem cells and potentially involved in the niche-mediated regulation of the side population phenotype.

Authors:  Fumi Shibata; Yuko Goto-Koshino; Yoshihiro Morikawa; Tadasuke Komori; Miyuki Ito; Yumi Fukuchi; Jeffrey P Houchins; Monica Tsang; Dean Y Li; Toshio Kitamura; Hideaki Nakajima
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

10.  Overcoming the response plateau in multiple myeloma: a novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization.

Authors:  Ruben Niesvizky; Tomer M Mark; Maureen Ward; David S Jayabalan; Roger N Pearse; Megan Manco; Jessica Stern; Paul J Christos; Lena Mathews; Tsiporah B Shore; Faiza Zafar; Karen Pekle; Zhaoying Xiang; Scott Ely; Donna Skerret; Selina Chen-Kiang; Morton Coleman; Maureen E Lane
Journal:  Clin Cancer Res       Date:  2013-01-28       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.